Analysts Issuing 'Sell Reports' Allowed to Remain Anonymous... Move Aims to Curb Sales Divisions' Influence
- Input
- 2026-10-01 10:56:45
- Updated
- 2026-10-01 10:56:45

[Financial News] Financial authorities have decided to block undue influence from brokerage sales and corporate-finance divisions over securities research reports and incorporate objective indicators, such as target-price deviation rates, into analyst evaluations. To address the industry’s bias toward buy recommendations, analysts will be allowed to withhold their names when issuing sell recommendations.
The FSC said on the 1st that it had discussed comprehensive measures to improve the research system at the second meeting of the 'Consultative Body for Strengthening Venture Capital Capabilities in the Financial Investment Sector,' held at the Korea Financial Investment Association on the 30th of last month.
Sell recommendations account for less than 1% of all research reports issued by domestic brokerages. Critics have continued to point out that reports are being issued mainly with buy recommendations while taking into account the potential impact on corporate-finance operations and sales divisions.
Financial authorities will elevate the current principle prohibiting undue influence over research departments, which is set out in Korea Financial Investment Association regulations, into the Financial Investment Business Regulations. They will also pursue measures to ensure that research department budgets do not become excessively dependent on individual and corporate sales or corporate-finance division revenues.
New management rules will also be introduced for cases in which analysts support sales division activities. Analysts will be restricted from explaining information beyond research reports or publicly available data and will be required to report such activities to a compliance officer in advance. After the support is provided, the compliance officer will manage and supervise the activity.
Excessive influence from sales divisions will also be excluded from analyst performance evaluations. Objective indicators, including the deviation rate showing the difference between the actual share price and the target price, will be reflected in evaluations, while industry-specific deviation rates will be calculated annually. Industries whose average deviation rate in the previous year is higher than the average for the most recent five years will be analyzed and managed separately.
Brokerages will periodically disclose their research-report issuance records and the top five analysts with the best deviation rates. When a brokerage stops issuing reports on a particular stock, it must provide specific reasons, such as a deterioration in the company's outlook, increased volatility following a sharp rise in the share price, delisting, or the departure of the analyst in charge. When reports resume, the brokerage must also state that they had previously been suspended and provide the reasons for the suspension and resumption.
Analysts issuing sell recommendations will be allowed to choose whether to include their names in the reports. The measure is intended to reduce the burden associated with issuing sell recommendations. However, prior approval from a compliance officer will be required, and brokerages must internally record and manage information on the approval process and the report's author.
Measures to expand research coverage of small- and mid-cap stocks have also been prepared. Of the 85,030 research reports issued over the past three years, only 14,648, or 17.2%, covered companies ranked outside the top 300 by market capitalization. By contrast, reports on companies ranked from first to 100th by market capitalization accounted for 41,239 reports, or 48.5%.
Financial authorities will introduce a minimum small-cap research coverage ratio for comprehensive financial investment firms and provide incentives when calculating the mandatory venture-capital ratio for firms with high coverage. Specifically, they are considering requiring at least one-quarter of annual reports to cover small- and mid-cap stocks and adding 5% of the amount supplied to small and venture companies when calculating the supply amount for comprehensive financial investment firms whose small-cap research accounted for at least 40% of their coverage in the previous year.
They will also pursue incentives in calculating venture-capital supply performance for comprehensive financial investment firms whose research coverage of small- and mid-cap stocks accounted for at least 40% in the previous year. Under the proposed method, 5% of the amount supplied to small and venture companies would be added to the recognized amount. The obligation to publish research reports on companies preparing for an IPO will also be strengthened from at least twice a year for one year to at least twice annually for three years.
An FSC official said, "The government, relevant institutions and the financial investment industry will jointly review the progress of venture-capital supply efforts each quarter and continue discussing major pending issues. We will communicate closely with the industry and make improvements so that the comprehensive measures to improve the research system are implemented smoothly in the field."
[email protected] Lee Jeong-hwa Reporter